DeepThal: A Deep Learning-Based Framework for the Large-Scale Prediction of the α<sup>+</sup>-Thalassemia Trait Using Red Blood Cell Parameters
Issued Date
2022-11-01
Resource Type
eISSN
20770383
Scopus ID
2-s2.0-85141792114
Journal Title
Journal of Clinical Medicine
Volume
11
Issue
21
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Medicine Vol.11 No.21 (2022)
Suggested Citation
Phirom K., Charoenkwan P., Shoombuatong W., Charoenkwan P., Sirichotiyakul S., Tongsong T. DeepThal: A Deep Learning-Based Framework for the Large-Scale Prediction of the α<sup>+</sup>-Thalassemia Trait Using Red Blood Cell Parameters. Journal of Clinical Medicine Vol.11 No.21 (2022). doi:10.3390/jcm11216305 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/85402
Title
DeepThal: A Deep Learning-Based Framework for the Large-Scale Prediction of the α<sup>+</sup>-Thalassemia Trait Using Red Blood Cell Parameters
Author's Affiliation
Other Contributor(s)
Abstract
Objectives: To develop a machine learning (ML)-based framework using red blood cell (RBC) parameters for the prediction of the α+-thalassemia trait (α+-thal trait) and to compare the diagnostic performance with a conventional method using a single RBC parameter or a combination of RBC parameters. Methods: A retrospective study was conducted on possible couples at risk for fetus with hemoglobin H (Hb H disease). Subjects with molecularly confirmed normal status (not thalassemia), α+-thal trait, and two-allele α-thalassemia mutation were included. Clinical parameters (age and gender) and RBC parameters (Hb, Hct, MCV, MCH, MCHC, RDW, and RBC count) obtained from their antenatal thalassemia screen were retrieved and analyzed using a machine learning (ML)-based framework and a conventional method. The performance of α+-thal trait prediction was evaluated. Results: In total, 594 cases (female/male: 330/264, mean age: 29.7 ± 6.6 years) were included in the analysis. There were 229 normal controls, 160 cases with the α+-thalassemia trait, and 205 cases in the two-allele α-thalassemia mutation category, respectively. The ML-derived model improved the diagnostic performance, giving a sensitivity of 80% and specificity of 81%. The experimental results indicated that DeepThal achieved a better performance compared with other ML-based methods in terms of the independent test dataset, with an accuracy of 80.77%, sensitivity of 70.59%, and the Matthews correlation coefficient (MCC) of 0.608. Of all the red blood cell parameters, MCH < 28.95 pg as a single parameter had the highest performance in predicting the α+-thal trait with the AUC of 0.857 and 95% CI of 0.816–0.899. The combination model derived from the binary logistic regression analysis exhibited improved performance with the AUC of 0.868 and 95% CI of 0.830–0.906, giving a sensitivity of 80.1% and specificity of 75.1%. Conclusions: The performance of DeepThal in terms of the independent test dataset is sufficient to demonstrate that DeepThal is capable of accurately predicting the α+-thal trait. It is anticipated that DeepThal will be a useful tool for the scientific community in the large-scale prediction of the α+-thal trait.